Apple will remove the blood oxygen measuring feature from some of its latest Apple Watches in the United States in a move that will allow the company to continue selling the devices in the country as it fights a lawsuit against California-based health technology firm Masimo.
The company said in a statement that the Apple Watch Series 9 and Ultra 2 model smartwatches will start going on sale on Thursday, reported Reuters. The company has been embroiled in a legal dispute with Masimo, which manufactures medical devices, ever since the International Trade Commission (ITC) in October found that its smartwatches had sensors that infringed upon Masimo’s patents.
